PresentationSusmita Roy Good afternoon, everyone. My name is Susmita Roy. I'm an associate on the health care investment banking team here at JPMorgan. On behalf of JPMorgan, first of all, welcome. Thank you so much for taking the time to attend the conference. It's been a great conference so far. And to continue the festivities rolling, I'm thrilled to introduce Entrada Therapeutics for their company presentation today. A little bit about Entrada before we get started. Entrada is focused on treating devas ...

TSMC, the world's largest contract chipmaker, posted a 35% jump in fourth-quarter net profit on Thursday, beating market forecasts and hitting a record as it benefited from surging demand for semicond... ...

PresentationWelcome, everyone. My name is [ Tai Pavumi ], and I'm welcoming you to the 44th JPMorgan Healthcare Conference. Our next presenting company is Protara Therapeutics. Protara is a clinical stage biotechnology company that's developing transformative therapies for people with rare cancer diseases. And presenting today is CEO, Jesse Shefferman. Please help me welcoming to the stage.Jesse SheffermanCo-founder, CEO, President & Director Thank you. Thanks, [ Tai ]. Thank you to the JPMorgan team for ha ...

PresentationGood afternoon, everyone. Thank you so much for joining us for another session at the 44th JPMorgan Healthcare Conference. I'm Brian Cheng. I'm one of the senior biotech analysts here at the firm. On stage, we have Ascentage Pharma. I'll now pass the mic to the CEO, Dr. Dajun Yang, for a short presentation, followed by a live audience Q&A. Dr. Yang, welcome. The stage is yours.Dajun YangCo-Founder, Chairman & CEO Thank you. Really honored to be here at the main conference presentation for the fi ...

PresentationHi, everyone. Hope you're enjoying day 3 of the JPMorgan Healthcare Conference. My name is Vidhushi Taduri, and I'm an associate in the health care team here at JPM. It's my pleasure to introduce XVIVO's CEO, Christoffer Rosenblad, who will be presenting to you today. Over to you.Christoffer RosenbladChief Executive Officer Thank you so much, and welcome to XVIVO's presentation. XVIVO is a company that scientifically pushed the boundaries of organ care prior to transplantation. And since you so ...

For the first time, we moved on to analysing a yacht manufacturer. While this may appear unconventional for our readers, it is a natural extension of our long-standing focus on luxury goods. Sanlorenzo ( SNLRFBuy-side hedge professionals conducting fundamental, income oriented, long term analysis across sectors globally in developed markets. Please shoot us a message or leave a comment to discuss ideas.DISCLOSURE: All of our articles are a matter of opinion, informed as they might be, and must be treated as ...

Microsoft has agreed with Indigo Carbon to buy a record 2.85 million soil carbon credits linked to regenerative agriculture in the United States, as the tech giant aims to become "carbon negative" by ... ...

Purpose-built to enable organizations to deploy their own secured, compliant and automated environments for AI-ready sovereign workloads Digital sovereignty goes beyond data residency. It encompasses who operates and controls the technology environment, how data is accessed and governed, where workloads execute, and under whose jurisdiction AI models run. Yet most organizations lack a destination to land, modernize, and re-host applications under sovereign control, including applications that will incorpora ...

Goldman Sachs CEO David Solomon speaks during an interview at the Economic Club of Washington in Washington, D.C., U.S., Oct. 30, 2025.Goldman Sachs is scheduled to report fourth-quarter earnings before the opening bell Thursday.Here's what Wall Street expects:Earnings: $11.67 per share, according to LSEGRevenue: $13.79 billion, according to LSEGTrading revenue: Fixed income of $2.93 billion, equities of $3.70 billion, per StreetAccountInvesting banking fees: $2.58 billion, per StreetAccountGoldman Sachs is ...

Cognizant's study shows AI is accelerating faster than projected, with 93% of jobs potentially affected today Findings also point to the limits of AI's impact, with skilling and human judgment playing a critical role in how organizations capture AI's full value TEANECK, N.J., Jan. 15, 2026 /PRNewswire/ -- Cognizant today announced the release of "New Work, New World 2026," providing fresh analysis on how artificial intelligence (AI) will impact work and jobs. Building on the original report's release in 202 ...